question and answer on Twitter



[ad_1]

The controversy after the words of the head of intensive care of San Raffaele about the hospitalization of Silvio Berlusconi: “He would die in March”

Question and controversy about Twitter between the journalist Selvaggia Lucarelli and the head of intensive care at San Raffaele Alberto Zangrillo. After the doctor, referring to Silvio Berlusconi, hospitalized with bilateral coronavirus pneumonia, declared that “in March-April he would die”, the journalist wrote on social networks: “Zangrì, let’s say that in March, meanwhile, Berlusconi would have found a place in intensive care, while another is 83 years old … “Zangrillo’s own response was very close:” You are a vulgar and bad woman. I say this in defense of the doctors and nurses who have worked by my side, tirelessly to save the last of the last. God forgive me. She. ”Lucarelli has again He commented: “Strange, because when he writes or calls me to try to sweeten me he calls me ‘very nice’. You will have understood that with me certain attempts are clinically dead “(PHOTO HISTORY OF BERLUSCONI – THE STAGES OF ITS LAST WEEKS – LIVE UPDATES ON CORONAVIRUS).

Zangrillo’s statements about Berlusconi

read also


Coronavirus, Zangrillo: “Berlusconi would have died in March-April”

“The viral load of Berlusconi’s nasopharyngeal swab was so high that in March-April, it certainly would not have had the result that it fortunately has now. Would it have killed him? Absolutely yes, probably yes, and he knows it. Boutade to exaggerate given the character we are talking about, but it is an attempt to remain adherent to reality “, declared yesterday the chief doctor of San Raffaele, guest of Clean slate its La7. “Let’s say that” Briatore and Berlusconi “are in more than satisfactory situations, they are doing well, for them I think that the epilogue of this disease is near,” he added. In the afternoon, the bulletin signed by Zangrillo was released, stating that “one week after hospitalization for the treatment of bilateral pneumonia related to SARS-COV-2, an optimal response to therapies is observed in course”.



[ad_2]